Australia's Kazia enrolls its investigational drugs in glioblastoma clinical study

Pre Clinical Development |  News | 0 Comment | 19 Oct, 2020

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, announced that it has executed a defin...Read more

UK's Formedix expands to meet demands for clinical trial automation

Pre Clinical Development |  News | 0 Comment | 15 Oct, 2020

Formedix, a software organization based in Glasgow, UK, that provides a clinical trial automation platform to help compa...Read more

Scientific advisory board in Europe to address dysfunctional endothelium in COVID-19

Pre Clinical Development |  News | 0 Comment | 14 Oct, 2020

After encouraging results obtained under named patient use in severe cases of COVID-19,  F4 Pharma is now prep...Read more